These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 34381692)

  • 1. Immune thrombocytopenia associated with Pfizer-BioNTech's BNT162b2 mRNA COVID-19 vaccine.
    Akiyama H; Kakiuchi S; Rikitake J; Matsuba H; Sekinada D; Kozuki Y; Iwata N
    IDCases; 2021; 25():e01245. PubMed ID: 34381692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Case of Immune Thrombocytopenia After BNT162b2 mRNA COVID-19 Vaccination.
    King ER; Towner E
    Am J Case Rep; 2021 Jul; 22():e931478. PubMed ID: 34285180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Thrombocytopenia Exacerbation After COVID-19 Vaccination in a Young Woman.
    Fujita M; Ureshino H; Sugihara A; Nishioka A; Kimura S
    Cureus; 2021 Sep; 13(9):e17942. PubMed ID: 34660131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 vaccination associated severe immune thrombocytopenia.
    Shah SRA; Dolkar S; Mathew J; Vishnu P
    Exp Hematol Oncol; 2021 Jul; 10(1):42. PubMed ID: 34266487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe immune thrombocytopenia following diphtheria, tetanus, pertussis and polio vaccination in a 36-year-old Caucasian woman: a case report.
    Küster O; Schmohl J; Greiner J; Storz MA
    Eur J Med Res; 2022 May; 27(1):63. PubMed ID: 35505368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immune thrombocytopenia after BNT162b2 mRNA COVID-19 vaccination].
    Sato K; Anayama M; Sumi M; Kobayashi H
    Rinsho Ketsueki; 2021; 62(12):1688-1693. PubMed ID: 35022338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia.
    Gordon SF; Clothier HJ; Morgan H; Buttery JP; Phuong LK; Monagle P; Chunilal S; Wood EM; Tran H; Szer J; Crawford NW;
    Vaccine; 2021 Nov; 39(48):7052-7057. PubMed ID: 34756770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immune thrombocytopenia after BNT162b2 mRNA COVID-19 vaccination].
    Matsumura A; Katsuki K; Akimoto M; Sakuma T; Nakajima Y; Miyazaki T; Fujisawa S; Nakajima H
    Rinsho Ketsueki; 2021; 62(11):1639-1642. PubMed ID: 34866090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine-associated thrombocytopenia.
    Gan G; Liu H; Liang Z; Zhang G; Liu X; Ma L
    Thromb Res; 2022 Dec; 220():12-20. PubMed ID: 36265409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vigilance regarding immune thrombocytopenic purpura after COVID-19 vaccine.
    Saudagar V; Patil S; Goh S; Pothiawala S
    Ir J Med Sci; 2022 Apr; 191(2):919-920. PubMed ID: 33788135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quick drop of platelet counts in children with chronic immune thrombocytopenia after COVID-19 mRNA vaccination: case reports.
    Lassandro G; Carriero F; Palladino V; Del Vecchio GC; Giordano P
    Clin Exp Vaccine Res; 2022 Sep; 11(3):290-293. PubMed ID: 36451665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Case Report of Immune Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
    Kim G; Choi EJ; Park HS; Lee JH; Lee JH; Lee KH
    J Korean Med Sci; 2021 Nov; 36(43):e306. PubMed ID: 34751013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune thrombocytopenia and COVID-19 vaccination: Outcomes and comparisons to prepandemic patients.
    Choi PY; Hsu D; Tran HA; Tan CW; Enjeti A; Chen VMY; Merriman E; Yong ASM; Simpson J; Gardiner E; Cherbuin N; Curnow J; Pepperell D; Bird R
    Res Pract Thromb Haemost; 2023 Jan; 7(1):100009. PubMed ID: 36531670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Systematic Review of Reported Cases of Immune Thrombocytopenia after COVID-19 Vaccination.
    Saluja P; Amisha F; Gautam N; Goraya H
    Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombocytopenic purpura after measles-mumps-rubella vaccination: a systematic review of the literature and guidance for management.
    Mantadakis E; Farmaki E; Buchanan GR
    J Pediatr; 2010 Apr; 156(4):623-8. PubMed ID: 20097358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Severe thrombocytopenia after COVID-19 mRNA vaccination].
    Hagihara M; Uchida T; Inoue M; Ohara S; Imai Y
    Rinsho Ketsueki; 2021; 62(12):1684-1687. PubMed ID: 35022337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS).
    Welsh KJ; Baumblatt J; Chege W; Goud R; Nair N
    Vaccine; 2021 Jun; 39(25):3329-3332. PubMed ID: 34006408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of hematologic adverse events reported to a national surveillance system following COVID-19 bivalent booster vaccination.
    Jacobs JW; Booth GS; Adkins BD
    Ann Hematol; 2023 Apr; 102(4):955-959. PubMed ID: 36795118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of heterologous primary and booster schedules with ChAdOx1-S and BNT162b2 or mRNA-1273 vaccines: nationwide cohort study.
    Andersson NW; Thiesson EM; Laursen MV; Mogensen SH; Kjær J; Hviid A
    BMJ; 2022 Jul; 378():e070483. PubMed ID: 35831006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines for measles, mumps, rubella, and varicella in children.
    Di Pietrantonj C; Rivetti A; Marchione P; Debalini MG; Demicheli V
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD004407. PubMed ID: 32309885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.